Why Credit Corp, GUD, Race Oncology, and Spartan Resources shares are rising

These shares are having a decent session. But why?

| More on:
A man sees some good news on his phone and gives a little cheer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a tough session on Tuesday. In afternoon trade, the benchmark index is down 0.4% to 7,719.1 points.

Four ASX shares that are not letting that hold them back today are listed below. Here's why they are rising:

Credit Corp Group Limited (ASX: CCP)

The Credit Corp share price is up almost 4% to $15.44. Investors have been buying this debt collector's shares on Tuesday after they were the subject of a bullish broker note out of Macquarie. According to the note, the broker has upgraded Credit Corp's shares to an outperform rating with an $18.32 price target. Macquarie highlights that the company's shares are trading at a deep discount to long term multiples. It feels this make now an opportune time for investors to initiate an investment. And judging by its gain today, it seems that the investors agree.

GUD Holdings Limited (ASX: GUD)

The GUD Holdings share price is up 11.5% to $10.90. This has been driven by the release of a trading update from the auto parts company. Management revealed that it remains on course to achieve its guidance in FY 2024. This will mean underlying earnings before interest, taxes and amortisation (EBITA) of at least $193.5 million. That's despite its AutoPacific Group (APG) segment performing a touch below expectations. Management revealed that this reflects the ongoing execution of its diversification strategy and the resilience of the aftermarket parts market.

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price is up 8% to $1.67. This follows the release of results from recent preclinical work performed under contract at Oncolines in the Netherlands. The release notes that in these studies, its bisantrene product was screened in combination with decitabine for enhanced anticancer activity across a broad panel of 143 cancer cell lines. Race CEO, Dr Daniel Tillett, commented: "These results open exciting new treatment opportunities for both bisantrene and decitabine."

Spartan Resources Ltd (ASX: SPR)

The Spartan Resources share price is up 3% to 65.3 cents. This morning, this gold developer revealed that it has completed the retail component of its fully underwritten pro rata accelerated non-renounceable entitlement offer. The retail entitlement offer raised a total of approximately $11 million at the offer price of 58 cents per new share. This brings the total raised to approximately $80 million. Proceeds will be used to underpin a significantly expanded exploration campaign at the Dalgaranga Gold Project.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A man wearing glasses and a white t-shirt pumps his fists in the air looking excited and happy about the rising OBX share price
Share Gainers

These were the best performing ASX 200 shares in May 2024

These shares made their shareholders smile in May.

Read more »

Three hikers lift their arms in jubilation as they reach a rocky peak overlooking a sensational view of water and mountains with a blue sky surrounding them.
Share Market News

Guess which 3 ASX 200 shares are leading the charge higher this week

Investors piled into these three ASX 200 shares over the week. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

Why AVITA Medical, Catapult, Meridian Energy, and Telix shares are storming higher today

These ASX shares are ending the week strongly. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Guess which All Ords ASX healthcare share just rocketed 19% on major FDA news

Investors are bidding up the ASX healthcare share following good news from the US FDA.

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

Why is the Telix Pharmaceuticals share price soaring 11% today?

The Telix Pharmaceuticals share price is rocketing on Friday. But why?

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Catapult, Clarity, Pro Medicus, and Qantas shares are rising today

These shares are avoiding the market weakness on Thursday and pushing higher. But why?

Read more »

Man pointing at a blue rising share price graph.
Share Gainers

Guess which ASX microcap stock just rocketed 109% on a new deal!

Investors are sending the ASX microcap stock soaring on Thursday. But why?

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Share Gainers

3 ASX All Ords shares smashing new multi-year highs while the market sinks

Investors are sending these 3 ASX All Ords shares to multi-year highs on Thursday. But why?

Read more »